No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
2 | Adipocytokine signaling pathway 3 genes, 8 drugs (DrugBank) and 44 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
3 | African trypanosomiasis 3 genes, 7 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
4 | AGE-RAGE signaling pathway in diabetic complications 3 genes, 8 drugs (DrugBank) and 44 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
5 | Allograft rejection 5 genes, 8 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
6 | Alzheimer disease 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
7 | Amoebiasis 4 genes, 8 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
8 | AMPK signaling pathway 1 gene, 2 drugs (DrugBank) and 18 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
9 | Amyotrophic lateral sclerosis (ALS) 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Antifolate resistance 4 genes, 8 drugs (DrugBank) and 55 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | Antigen processing and presentation 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
12 | Apoptosis 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
13 | Arachidonic acid metabolism 2 genes, 10 drugs (DrugBank) and 22 diseases shown |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D03716 |
Parecoxib |
2件: 46, 271 |
14 | Asthma 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
15 | Autoimmune thyroid disease 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
16 | B cell receptor signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
17 | Bile secretion 1 gene, 2 drugs (DrugBank) and 18 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
18 | C-type lectin receptor signaling pathway 6 genes, 20 drugs (DrugBank) and 58 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
19 | Calcium signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: PTGER3 |
D00419 |
Misoprostol |
2件: 46, 271 |
20 | cAMP signaling pathway 7 genes, 3 drugs (DrugBank) and 6 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
2件: PTGER2, PTGER3 |
D00419 |
Misoprostol |
2件: 46, 271 |
21 | Cell adhesion molecules (CAMs) 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
22 | Cellular senescence 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
23 | Chagas disease (American trypanosomiasis) 4 genes, 8 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
24 | Chemical carcinogenesis 1 gene, 10 drugs (DrugBank) and 22 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
25 | Chemokine signaling pathway 3 genes, 2 drugs (DrugBank) and 10 diseases shown |
2件: JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
26 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
27 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
28 | Cocaine addiction 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
29 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
30 | Cytokine-cytokine receptor interaction 8 genes, 14 drugs (DrugBank) and 50 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
31 | Cytosolic DNA-sensing pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
32 | Dilated cardiomyopathy (DCM) 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
33 | EGFR tyrosine kinase inhibitor resistance 3 genes, 5 drugs (DrugBank) and 21 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
34 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
35 | Epstein-Barr virus infection 5 genes, 10 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
36 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: OPRM1 |
D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
D08623 |
37 | Fc epsilon RI signaling pathway 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
38 | Fluid shear stress and atherosclerosis 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
39 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
40 | Gastric acid secretion 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
41 | Graft-versus-host disease 3 genes, 7 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
42 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
43 | Hematopoietic cell lineage 3 genes, 9 drugs (DrugBank) and 68 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
44 | Hepatitis B 6 genes, 10 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
45 | Hepatitis C 4 genes, 10 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
46 | Herpes simplex virus 1 infection 8 genes, 11 drugs (DrugBank) and 46 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
47 | HIF-1 signaling pathway 2 genes, 3 drugs (DrugBank) and 17 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
48 | Human cytomegalovirus infection 8 genes, 23 drugs (DrugBank) and 61 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
3件: PTGER2, PTGER3, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
49 | Human immunodeficiency virus 1 infection 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
50 | Human papillomavirus infection 6 genes, 21 drugs (DrugBank) and 58 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
51 | Human T-cell leukemia virus 1 infection 6 genes, 13 drugs (DrugBank) and 50 diseases shown |
1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
D07119 |
D00941 |
Pamidronic acid |
2件: 271, 274 |
D07281 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
52 | Hypertrophic cardiomyopathy (HCM) 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
53 | IL-17 signaling pathway 5 genes, 20 drugs (DrugBank) and 57 diseases shown |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
54 | Inflammatory bowel disease (IBD) 7 genes, 13 drugs (DrugBank) and 45 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
55 | Inflammatory mediator regulation of TRP channels 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: PTGER2, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
56 | Influenza A 8 genes, 14 drugs (DrugBank) and 50 diseases shown |
1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
D07119 |
D00941 |
Pamidronic acid |
2件: 271, 274 |
D07281 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
57 | Insulin resistance 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
58 | Intestinal immune network for IgA production 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
59 | JAK-STAT signaling pathway 8 genes, 8 drugs (DrugBank) and 27 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
60 | Kaposi sarcoma-associated herpesvirus infection 6 genes, 15 drugs (DrugBank) and 39 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
61 | Legionellosis 4 genes, 8 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
62 | Leishmaniasis 7 genes, 21 drugs (DrugBank) and 59 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
63 | Longevity regulating pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
64 | Malaria 2 genes, 7 drugs (DrugBank) and 45 diseases shown |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
65 | MAPK signaling pathway 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
66 | Measles 6 genes, 5 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
67 | Metabolic pathways 13 genes, 19 drugs (DrugBank) and 65 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
D07119 |
D00941 |
Pamidronic acid |
2件: 271, 274 |
D07281 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D03716 |
Parecoxib |
2件: 46, 271 |
68 | MicroRNAs in cancer 2 genes, 11 drugs (DrugBank) and 23 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
69 | Morphine addiction 5 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: OPRM1 |
D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
D08623 |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
70 | mTOR signaling pathway 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
71 | Natural killer cell mediated cytotoxicity 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
72 | Necroptosis 5 genes, 9 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
73 | Neuroactive ligand-receptor interaction 7 genes, 6 drugs (DrugBank) and 59 diseases shown |
2件: CNR1, CNR2 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
1件: NR3C1 |
D00407 |
Methylprednisolone |
36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
D00751 |
D00979 |
D05000 |
D05001 |
D05002 |
D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
D00980 |
D00981 |
D00982 |
D01239 |
D01998 |
D02156 |
D03301 |
1件: OPRM1 |
D01355 |
Tramadol |
5件: 46, 70, 78, 226, 271 |
D08623 |
3件: PTGER2, PTGER3, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
74 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
75 | NF-kappa B signaling pathway 4 genes, 17 drugs (DrugBank) and 57 diseases shown |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
76 | NOD-like receptor signaling pathway 4 genes, 10 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
77 | Non-alcoholic fatty liver disease (NAFLD) 3 genes, 9 drugs (DrugBank) and 49 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
78 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
79 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
80 | Osteoclast differentiation 4 genes, 10 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
81 | Ovarian steroidogenesis 1 gene, 10 drugs (DrugBank) and 22 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
82 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
D01207 |
D05259 |
D05261 |
83 | Oxytocin signaling pathway 1 gene, 10 drugs (DrugBank) and 22 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
84 | Pancreatic cancer 2 genes, 4 drugs (DrugBank) and 12 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
85 | Parathyroid hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
86 | Pathogenic Escherichia coli infection 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
87 | Pathways in cancer 12 genes, 20 drugs (DrugBank) and 40 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
3件: PTGER2, PTGER3, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
88 | PD-L1 expression and PD-1 checkpoint pathway in cancer 3 genes, 4 drugs (DrugBank) and 12 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
89 | Pertussis 5 genes, 10 drugs (DrugBank) and 45 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
90 | PI3K-Akt signaling pathway 5 genes, 6 drugs (DrugBank) and 21 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
91 | Platelet activation 1 gene, 6 drugs (DrugBank) and 17 diseases shown |
1件: PTGS1 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
92 | Primary immunodeficiency 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
93 | Prolactin signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
94 | Prostate cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
95 | Proteoglycans in cancer 2 genes, 7 drugs (DrugBank) and 45 diseases shown |
1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
96 | Purine metabolism 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D08860 |
Apremilast |
5件: 46, 50, 56, 97, 271 |
97 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
98 | Rap1 signaling pathway 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
99 | Ras signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
100 | Regulation of lipolysis in adipocytes 3 genes, 11 drugs (DrugBank) and 22 diseases shown |
1件: PTGER3 |
D00419 |
Misoprostol |
2件: 46, 271 |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D03716 |
Parecoxib |
2件: 46, 271 |
101 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
102 | Renin secretion 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: PTGER2, PTGER4 |
D00419 |
Misoprostol |
2件: 46, 271 |
103 | Retrograde endocannabinoid signaling 2 genes, 12 drugs (DrugBank) and 31 diseases shown |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
104 | Rheumatoid arthritis 5 genes, 13 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL17A |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
105 | RIG-I-like receptor signaling pathway 4 genes, 8 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
106 | Salmonella infection 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
107 | Serotonergic synapse 2 genes, 10 drugs (DrugBank) and 22 diseases shown |
2件: PTGS1, PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D03716 |
Parecoxib |
2件: 46, 271 |
108 | Shigellosis 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
109 | Signaling pathways regulating pluripotency of stem cells 3 genes, 3 drugs (DrugBank) and 12 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
110 | Small cell lung cancer 2 genes, 11 drugs (DrugBank) and 23 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
111 | Sphingolipid signaling pathway 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
112 | Systemic lupus erythematosus 3 genes, 7 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
113 | T cell receptor signaling pathway 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
114 | Terpenoid backbone biosynthesis 2 genes, 5 drugs (DrugBank) and 25 diseases shown |
1件: FDPS |
D00939 |
Alendronic acid |
7件: 19, 41, 46, 50, 271, 274, 299 |
D07119 |
D00941 |
Pamidronic acid |
2件: 271, 274 |
D07281 |
D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
D06378 |
D06379 |
D08689 |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
D07474 |
D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
D08492 |
115 | TGF-beta signaling pathway 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
116 | Th1 and Th2 cell differentiation 7 genes, 5 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
117 | Th17 cell differentiation 9 genes, 12 drugs (DrugBank) and 28 diseases shown |
1件: IL17A |
D10071 |
Ixekizumab |
4件: 37, 162, 269, 271 |
D09967 |
Secukinumab |
7件: 13, 37, 41, 46, 160, 269, 271 |
2件: IL17A, IL17F |
D11550 |
Bimekizumab |
3件: 46, 97, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
118 | Thermogenesis 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
D00306 |
Dronabinol |
5件: 2, 13, 46, 271, 298 |
119 | TNF signaling pathway 4 genes, 17 drugs (DrugBank) and 57 diseases shown |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
120 | Toll-like receptor signaling pathway 6 genes, 9 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
121 | Toxoplasmosis 7 genes, 11 drugs (DrugBank) and 46 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
122 | Transcriptional misregulation in cancer 2 genes, 2 drugs (DrugBank) and 24 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
123 | Tuberculosis 7 genes, 13 drugs (DrugBank) and 46 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL23A |
D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
D10400 |
Tildrakizumab |
1件: 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
124 | Type I diabetes mellitus 6 genes, 8 drugs (DrugBank) and 51 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
125 | Type II diabetes mellitus 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
126 | VEGF signaling pathway 1 gene, 10 drugs (DrugBank) and 22 diseases shown |
1件: PTGS2 |
D00217 |
Acetaminophen |
13件: 3, 6, 13, 34, 35, 46, 49, 51, 70, 86, 231, 256, 271 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
D00903 |
Diclofenac |
4件: 13, 34, 46, 271 |
D00904 |
D07816 |
D03710 |
Etoricoxib |
2件: 46, 271 |
D00126 |
Ibuprofen |
6件: 13, 46, 65, 113, 271, 299 |
D01122 |
D04490 |
D06606 |
D00141 |
Indometacin |
2件: 225, 271 |
D01565 |
D02110 |
D08149 |
Loxoprofen |
2件: 46, 271 |
D00969 |
Meloxicam |
4件: 46, 49, 271, 296 |
D00118 |
Naproxen |
3件: 13, 46, 271 |
D03716 |
Parecoxib |
2件: 46, 271 |
127 | Viral carcinogenesis 3 genes, 4 drugs (DrugBank) and 12 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
128 | Viral myocarditis 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
129 | Viral protein interaction with cytokine and cytokine receptor 3 genes, 8 drugs (DrugBank) and 49 diseases shown |
1件: IL6R |
D10161 |
Sarilumab |
5件: 41, 46, 84, 107, 271 |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
130 | Yersinia infection 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |